MNK-010
- Generic Name
- MNK-010
Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 44
- Registration Number
- NCT02040558
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath